256 related articles for article (PubMed ID: 31343786)
1. Mitochondrial targets of metformin-Are they physiologically relevant?
Pecinová A; Brázdová A; Drahota Z; Houštěk J; Mráček T
Biofactors; 2019 Sep; 45(5):703-711. PubMed ID: 31343786
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial metabolism and type-2 diabetes: a specific target of metformin.
Leverve XM; Guigas B; Detaille D; Batandier C; Koceir EA; Chauvin C; Fontaine E; Wiernsperger NF
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S88-94. PubMed ID: 14502105
[TBL] [Abstract][Full Text] [Related]
3. Metformin as an Anticancer Agent.
Vancura A; Bu P; Bhagwat M; Zeng J; Vancurova I
Trends Pharmacol Sci; 2018 Oct; 39(10):867-878. PubMed ID: 30150001
[TBL] [Abstract][Full Text] [Related]
4. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells.
Kukidome D; Nishikawa T; Sonoda K; Imoto K; Fujisawa K; Yano M; Motoshima H; Taguchi T; Matsumura T; Araki E
Diabetes; 2006 Jan; 55(1):120-7. PubMed ID: 16380484
[TBL] [Abstract][Full Text] [Related]
5. Metformin and Breast Cancer: Molecular Targets.
Faria J; Negalha G; Azevedo A; Martel F
J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
[TBL] [Abstract][Full Text] [Related]
6. Metformin protects high glucose‑cultured cardiomyocytes from oxidative stress by promoting NDUFA13 expression and mitochondrial biogenesis via the AMPK signaling pathway.
Liu XD; Li YG; Wang GY; Bi YG; Zhao Y; Yan ML; Liu X; Wei M; Wan LL; Zhang QY
Mol Med Rep; 2020 Dec; 22(6):5262-5270. PubMed ID: 33174032
[TBL] [Abstract][Full Text] [Related]
7. Metformin: from mechanisms of action to therapies.
Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
[TBL] [Abstract][Full Text] [Related]
8. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
Shaw RJ; Lamia KA; Vasquez D; Koo SH; Bardeesy N; Depinho RA; Montminy M; Cantley LC
Science; 2005 Dec; 310(5754):1642-6. PubMed ID: 16308421
[TBL] [Abstract][Full Text] [Related]
9. Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis.
Griss T; Vincent EE; Egnatchik R; Chen J; Ma EH; Faubert B; Viollet B; DeBerardinis RJ; Jones RG
PLoS Biol; 2015 Dec; 13(12):e1002309. PubMed ID: 26625127
[TBL] [Abstract][Full Text] [Related]
10. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
An H; He L
J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
[TBL] [Abstract][Full Text] [Related]
11. Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation.
Kim KH; Jeong YT; Kim SH; Jung HS; Park KS; Lee HY; Lee MS
Biochem Biophys Res Commun; 2013 Oct; 440(1):76-81. PubMed ID: 24041694
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk in type 2 diabetes.
Kong AP; Chan JC
Curr Diab Rep; 2012 Aug; 12(4):325-8. PubMed ID: 22562651
[No Abstract] [Full Text] [Related]
13. Targeting AMPK: From Ancient Drugs to New Small-Molecule Activators.
Guigas B; Viollet B
Exp Suppl; 2016; 107():327-350. PubMed ID: 27812986
[TBL] [Abstract][Full Text] [Related]
14. Metformin Protects H9C2 Cardiomyocytes from High-Glucose and Hypoxia/Reoxygenation Injury via Inhibition of Reactive Oxygen Species Generation and Inflammatory Responses: Role of AMPK and JNK.
Hu M; Ye P; Liao H; Chen M; Yang F
J Diabetes Res; 2016; 2016():2961954. PubMed ID: 27294149
[TBL] [Abstract][Full Text] [Related]
15. Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK.
Wang Y; An H; Liu T; Qin C; Sesaki H; Guo S; Radovick S; Hussain M; Maheshwari A; Wondisford FE; O'Rourke B; He L
Cell Rep; 2019 Nov; 29(6):1511-1523.e5. PubMed ID: 31693892
[TBL] [Abstract][Full Text] [Related]
16. Molecular action of metformin in hepatocytes: an updated insight.
Sliwinska A; Drzewoski J
Curr Diabetes Rev; 2015; 11(3):175-81. PubMed ID: 25808533
[TBL] [Abstract][Full Text] [Related]
17. Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer.
Hinke SA; Martens GA; Cai Y; Finsi J; Heimberg H; Pipeleers D; Van de Casteele M
Br J Pharmacol; 2007 Apr; 150(8):1031-43. PubMed ID: 17339833
[TBL] [Abstract][Full Text] [Related]
18. AMP-activated protein kinase: a target for drugs both ancient and modern.
Hardie DG; Ross FA; Hawley SA
Chem Biol; 2012 Oct; 19(10):1222-36. PubMed ID: 23102217
[TBL] [Abstract][Full Text] [Related]
19. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus.
Foretz M; Guigas B; Viollet B
Nat Rev Endocrinol; 2019 Oct; 15(10):569-589. PubMed ID: 31439934
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic Effects of Biguanides on Mitochondrial Reactive Oxygen Species Production.
Pecinova A; Drahota Z; Kovalcikova J; Kovarova N; Pecina P; Alan L; Zima M; Houstek J; Mracek T
Oxid Med Cell Longev; 2017; 2017():7038603. PubMed ID: 28874953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
